Recent Trends of Helicobacter pylori Eradication Therapy in Korea
The Korean Journal of Helicobacter and Upper Gastrointestinal Research
; : 219-223, 2012.
Article
in Korean
| WPRIM (Western Pacific)
| ID: wpr-134408
Responsible library:
WPRO
ABSTRACT
Helicobacter pylori infection is one of the most common gastrointestinal infectious diseases in Korea and is related to diseases such as gastritis, peptic ulcer disease, marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type, and gastric adenocarcinoma. The eradication of H. pylori infection requires combinations of antibiotics and acid suppressants. Triple therapy has been considered as the first-line therapy for a long time. However, its eradication rate is declining and we need more effective strategies. Quadruple therapy including acid suppressants, bismuth, and other two antibiotics is a main rescue therapy after first-line therapy failure in Korea. In this review, we describe new therapeutic regimens and new trends of H. pylori eradication in Korea.
Full text:
Available
Health context:
SDG3 - Health and Well-Being
Health problem:
Target 3.3: End transmission of communicable diseases
Database:
WPRIM (Western Pacific)
Main subject:
Peptic Ulcer
/
Bismuth
/
Adenocarcinoma
/
Communicable Diseases
/
Helicobacter pylori
/
Helicobacter
/
Lymphoma, B-Cell, Marginal Zone
/
Gastritis
/
Korea
/
Lymphoid Tissue
Country/Region as subject:
Asia
Language:
Korean
Journal:
The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Year:
2012
Document type:
Article